New research indicates that some drugs prescribed to treat high blood pressure, namely calcium channel blockers (CCB) lead to an increased risk of developing pancreatic cancer in women. According to study lead author Zhensheng Wang, "the short-acting CCBs were the only blood pressure drugs linked to higher pancreatic cancer risk." Despite these findings, the research suggests that the absolute risk of developing pancreatic cancer after taking CCBs remains very low, about 1.6%.
To read more about this study, click here.
No comments:
Post a Comment